Daily Insider Ratings Round Up 2/27/20
Summary
- Tables of the top insider purchases and sales filed with the SEC on 2/27/20, based on dollar value.
- Dollar values often do not equate with significance when it comes to insider trades.
- Proprietary Insider Company Ratings are relayed to clarify significance.
- This idea was discussed in more depth with members of my private investing community, Daily Insider Ratings . Get started today »
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most important one.
When a new insider transaction occurs, our programs mathematically score the significance of the company's 3-month insider profile based on numerous criteria programmed into our expert system.
Stocks that achieve an InsiderInsights Company Rating of "Significant" and "Leaning" Bullish or Bearish have been independently validated to generate alpha as a group and should be considered by investors looking for new long and short investments.
Seasonal Note: Insider filing volumes are on the rise, and will stay strong through the end of March.
On Today's Tables:
Insider trades were rated Significant at :
- Safehold (SAFE)
- Voya Prime Rate Trust (PPR)
- Western Asset Global High Income Fund (EHI)
- Cinemark (CNK)
Insider trades were rated Nearly Significant at:
Insider trades were considered Insignificant at:
- Trinity Industries (TRN)
- Transunion (TRU)
- Trex Co. (TREX)
- Sei Inv (SEIC)
- SBA Comms (SBAC)
- Reliance Steel & Aluminum (RS)
- Pinnacle West Capital (PNW)
- Green Plains (GPRE)
- Fastly (FSLY)
- Charter Comms (CHTR)
There is a Conflicted Insider Signal (both purchases & sales) at:
Insider Purchases
| #: | Filer Name | Insider Titles | Company Name | Ticker | TransType | Dollar Value |
1 | Roivant Sciences | BO | Axovant Gene Therapies | AXGT | JB* | $19,999,998 |
2 | Winder Investment Pte | BO | Intl Flavors | IFF | B | $16,812,400 |
3 | Boze Brandon B | DIR, BO | Trinity Industries | TRN | AB | $5,730,800 |
4 | Istar | BO | Safehold | SAFE | AB | $2,572,200 |
5 | B Riley Financial | BO | Alta Equipment | ALTG | B | $2,238,207 |
6 | Mitchell Lee Roy | DIR | Cinemark | CNK | B | $1,997,908 |
7 | Saba Capital Mgt | BO | Western Asset Global High Income Fund | EHI | B | $1,743,854 |
8 | Gross Michael S | DIR | Solar Capital | SLRC | B | $795,820 |
9 | Saba Capital Mgt | BO | WA Hi Inc Opp Fd | HIO | B | $718,311 |
10 | Saba Capital Mgt | BO | Voya Prime Rate Trust | PPR | B | $697,026 |
Insider Sales
| #: | Filer Name | Insider Titles | Company Name | Ticker | TransType | Dollar Value |
1 | Bernstein Steven E | CB, DIR | SBA Comms | SBAC | S | $18,760,429 |
2 | West Alfred P Jr | BO | Sei Inv | SEIC | S | $11,762,097 |
3 | Hargis Jonathan | VP, SO | Charter Comms | CHTR | S | $5,220,712 |
4 | Hill Scott A | CFO | Intercontinental Exchange | ICE | AS | $2,550,616 |
5 | Danaher John T | PR | Transunion | TRU | AS | $2,285,543 |
6 | Lewis Karla R | VP, CFO | Reliance Steel & Aluminum | RS | S | $2,032,937 |
7 | Hatfield James R | VP, TR | Pinnacle West Capital | PNW | S | $1,986,718 |
8 | August Capital Mgt Vi | BO | Fastly | FSLY | S | $1,822,924 |
9 | Cline James E | CEO, DIR | Trex Co | TREX | AS | $1,222,290 |
10 | Mangrove Partners Master Fund | BO | Green Plains | GPRE | S | $1,016,899 |
Source: InsiderInsights.com. Key to Insider Title and Trans Type Codes: B = Open-market Buy; AB = 10b5-1 (automatic) Buy; JB* = Buy indicated as being open-market but not confirmed by trading price range and volume for the session. S = Open-market Sale; AS = 10b5-1 (automatic) Sale; JS* = Sale indicated as being open-market but not confirmed by trading price range and volume for the session.
Did you miss our Previous Daily Round Up?
If you're serious about using insider data in your investment process, you can't find a better source of investment ideas (or a better value!) than our Daily Ratings Reports. Subscribe or Trial Now!
This article was written by
Analyst’s Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.